Vertex Pharmaceuticals
VRTX
#198
Rank
NZ$190.69 B
Marketcap
NZ$749.69
Share price
1.27%
Change (1 day)
-5.80%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): NZ$7.95 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$12.00 Billion. , an increase over its 2024 earnings that were of NZ$0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 NZ$7.91 B1568.4%
2024 NZ$0.47 B-93.69%
2023 NZ$7.51 B3.19%
2022 NZ$7.28 B53.56%
2021 NZ$4.74 B-12.06%
2020 NZ$5.39 B118.45%
2019 NZ$2.46 B120.64%
2018 NZ$1.11 B1473.64%
2017 NZ$71.13 M197.6%
2016 NZ$23.9 M-102.97%
2015 -NZ$0.81 Billion-28.46%
2014 -NZ$1.13 Billion-51.5%
2013 -NZ$2.32 Billion-30584.68%
2012 NZ$7.6 M-95.47%
2011 NZ$0.16 B
2009 -NZ$1.01 Billion
2007 -NZ$0.71 Billion83.1%
2006 -NZ$0.39 Billion59.02%
2005 -NZ$0.25 Billion3.28%
2004 -NZ$0.24 Billion-38.16%
2003 -NZ$0.38 Billion
2000 -NZ$64.65 Million-20.38%
1999 -NZ$81.19 Million31.62%
1998 -NZ$61.69 Million91.05%
1997 -NZ$32.29 Million-36.24%
1996 -NZ$50.64 Million12.45%
1995 -NZ$45.03 Million27.4%
1994 -NZ$35.35 Million-1833.33%
1993 NZ$2.03 M-112.12%
1992 -NZ$16.83 Million175%
1991 -NZ$6.12 Million-12.2%
1990 -NZ$6.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$57.01 B 620.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$11.20 B 41.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.64 B 110.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.10 B 381.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$15.85 B 100.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-NZ$0.13 Billion-101.63%๐Ÿ‡บ๐Ÿ‡ธ USA